Dr. Sara Naseri: Menstrual blood as a diagnostic tool

It's estimated only one percent of medical research spending globally goes toward female-specific conditions that aren't related to cancer. But even as underfunding of women's health persists -- companies focused on women's health are innovating. Dr. Sara Naseri is working to reframe menstrual blood as a diagnostic tool rather than waste, with her company called Qvin. It received FDA clearance in January of this year for a new kind of blood test: a diagnostic menstrual pad. Plus, Axios senior health care editor Adriel Bettelheim on innovations in women's health. Guests: Dr. Sara Naseri, CEO and co-founder of Qvin; Axios' Adriel Bettelheim Credits: 1 big thing is produced by Niala Boodhoo, Alexandra Botti, and Jay Cowit. Music is composed by Alex Sugiura and Jay Cowit. You can reach us at podcasts@axios.com. You can send questions, comments and story ideas as a text or voice memo to Niala at 202-918-4893. Learn more about your ad choices. Visit megaphone.fm/adchoices

Om Podcasten

Axios podcast host Niala Boodhoo digs deep with leaders you know — or need to know — in business, politics and culture. Every week, all in under 20 minutes. About Axios: Axios is a digital media company launched in 2017. Axios helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app.  About Niala Boodhoo: Niala Boodhoo is the host of 1 big thing and previously hosted Axios Today She was the founding Host and Executive Producer of the award-winning news program The 21st. An alum of Reuters, The Miami Herald and WBEZ/Chicago, Niala was a 2019-2020 Knight-Wallace fellow.